Using Pipeline Embolization Device to treat intracranial aneurysms safely and effectively over time
Pipeline Embolization Device for the Treatment of Intracranial Aneurysms-A Real World Study on the Long Term Safety and Efficacy(POWER)
This study is testing how safe and effective the Pipeline Embolization Device is for treating brain aneurysms over a long period of time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 482 (estimated) |
| Sex | All |
| Sponsor | Xuanwu Hospital, Beijing Academic / other |
| Locations | 1 site (Beijing) |
| Trial ID | NCT06456697 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather data on the long-term safety and efficacy of the Pipeline Embolization Device (PED) for treating intracranial aneurysms. The study will analyze the effectiveness of the PED in promoting thrombosis formation within the aneurysm sac and inducing endothelial growth at the neck of the aneurysm. By evaluating outcomes from various follow-up periods, the study seeks to provide valuable insights and guidance for clinical practice in managing complex intracranial aneurysms.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with intracranial aneurysms who have had a Pipeline device successfully placed.
Not a fit: Patients who have previously undergone surgery or interventional treatment for their aneurysms may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance treatment protocols for patients with intracranial aneurysms, leading to improved safety and efficacy outcomes.
How similar studies have performed: Previous studies have shown promising results with the Pipeline Embolization Device, indicating its potential effectiveness in treating complex intracranial aneurysms.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The patient was diagnosed with intracranial aneurysms using digital subtraction angiography (DSA). 2. The pipeline was successfully placed to treat intracranial aneurysms. Exclusion Criteria: 1. Patients had undergone surgery or interventional treatment before enrollment. 2. During treatment, other types of stents are used in combination. 3. Unable to complete the follow-up.
Where this trial is running
Beijing
- Xuanwu Hospital, Capital Medical University — Beijing, China (Recruiting)
Study contacts
- Principal investigator: peng zhang, MD — Xuanwu Hospital, Beijing
- Study coordinator: peng zhang, MD
- Email: zhangpengwr@126.com
- Phone: 010-83198899
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.